FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W169768324> ?p ?o ?g. }

• W169768324 endingPage "2405" @default.
• W169768324 startingPage "2397" @default.
• W169768324 abstract "Abstract During development, mice with mutations of stem cell factor (SCF) or its receptor c-kit exhibit defects in melanogenesis, as well as hematopoiesis and gonadogenesis. Consequently, accumulating evidence suggests that the c-kit/SCF system plays a crucial role in all of these processes and in tumors which derive from them. Especially in neuroblastoma (infant tumors of neuroectoderm crest derivation such as melanocytes) it would appear that an autocrine loop exists between c-kit and SCF, and that the functional block of the c-kit receptors with monoclonal antibodies (MoAbs) results in a significant decrease in cellular proliferation. We studied the expression and role of c-kit and SCF in cell lines of soft tissue sarcoma of neuroectodermic origin, such as Ewing's sarcoma (ES) and peripheral neuro-ectodermal tumors (PNET). Using flow cytometry with MoAb CD117 PE, c-kit expression was highlighted in all six of the cell lines examined. This receptor was specifically and functionally activated by SCF, as shown by the binding experiments and the intracellular phosphotyrosine and immunoprecipitation studies that were performed. Using reverse transcriptase polymerase chain reaction analysis, five of the six cellular lines expressed the mRNA of SCF. In the medium measured by using an enzyme- linked immunosorbent assay, low concentrations of SCF were found: only the TC32 cellular line produced significantly higher levels (32 pg) than control. In serum-free culture the addition of SCF reduced the percentage of apoptotic cells from 25% to 90% in five out of the six cellular lines. This observation was confirmed by (1) the functional block of c-kit with MoAb: after 7 days of culture more than 30% of the cells were apoptotic (range 31.5% to 100%) in five out of six cell lines and there was also a decrease in the percentage of cells in phase S, and (2) c-kitantisense oligonucleotides: in the cellular lines treated with oligonucleotides (in relation to the untreated lines) there was a notable reduction (P < .001) both in the absolute number of cells and the 3H-thymidine uptake. These results indicate that ES and PNET express c-kit and its ligand SCF and that SCF is capable of protecting the tumor cells against apoptosis. Furthermore, the reverse transcriptase–polymerase chain reaction performed on the biopsies revealed the presence of mRNA both of SCF and c-kit in practically all of the samples studied. Our in vitro data lead us to assume that SCF may also inhibit tumor cell apoptosis in vivo." @default.
• W169768324 created "2016-06-24" @default.
• W169768324 creator A5007385075 @default.
• W169768324 creator A5009471007 @default.
• W169768324 creator A5021159865 @default.
• W169768324 creator A5022229677 @default.
• W169768324 creator A5023564102 @default.
• W169768324 creator A5028342529 @default.
• W169768324 creator A5038187666 @default.
• W169768324 creator A5051981929 @default.
• W169768324 creator A5052753597 @default.
• W169768324 creator A5062571587 @default.
• W169768324 creator A5073707704 @default.
• W169768324 creator A5090445073 @default.
• W169768324 date "1998-04-01" @default.
• W169768324 modified "2023-10-09" @default.
• W169768324 title "c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells" @default.
• W169768324 cites W1493060354 @default.
• W169768324 cites W1579093659 @default.
• W169768324 cites W159629284 @default.
• W169768324 cites W1752312133 @default.
• W169768324 cites W1981600520 @default.
• W169768324 cites W2023109494 @default.
• W169768324 cites W2037695813 @default.
• W169768324 cites W2053422110 @default.
• W169768324 cites W2053722592 @default.
• W169768324 cites W2087250323 @default.
• W169768324 cites W2128965225 @default.
• W169768324 cites W2140814882 @default.
• W169768324 cites W2151900782 @default.
• W169768324 cites W2440509111 @default.
• W169768324 cites W3110952719 @default.
• W169768324 cites W344470510 @default.
• W169768324 cites W4255620400 @default.
• W169768324 cites W69430954 @default.
• W169768324 doi "https://doi.org/10.1182/blood.v91.7.2397" @default.
• W169768324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9516139" @default.
• W169768324 hasPublicationYear "1998" @default.
• W169768324 type Work @default.
• W169768324 sameAs 169768324 @default.
• W169768324 citedByCount "100" @default.
• W169768324 countsByYear W1697683242012 @default.
• W169768324 countsByYear W1697683242015 @default.
• W169768324 countsByYear W1697683242020 @default.
• W169768324 countsByYear W1697683242022 @default.
• W169768324 crossrefType "journal-article" @default.
• W169768324 hasAuthorship W169768324A5007385075 @default.
• W169768324 hasAuthorship W169768324A5009471007 @default.
• W169768324 hasAuthorship W169768324A5021159865 @default.
• W169768324 hasAuthorship W169768324A5022229677 @default.
• W169768324 hasAuthorship W169768324A5023564102 @default.
• W169768324 hasAuthorship W169768324A5028342529 @default.
• W169768324 hasAuthorship W169768324A5038187666 @default.
• W169768324 hasAuthorship W169768324A5051981929 @default.
• W169768324 hasAuthorship W169768324A5052753597 @default.
• W169768324 hasAuthorship W169768324A5062571587 @default.
• W169768324 hasAuthorship W169768324A5073707704 @default.
• W169768324 hasAuthorship W169768324A5090445073 @default.
• W169768324 hasBestOaLocation W1697683241 @default.
• W169768324 hasConcept C101544691 @default.
• W169768324 hasConcept C109159458 @default.
• W169768324 hasConcept C128240485 @default.
• W169768324 hasConcept C153911025 @default.
• W169768324 hasConcept C170493617 @default.
• W169768324 hasConcept C2022786 @default.
• W169768324 hasConcept C28328180 @default.
• W169768324 hasConcept C502942594 @default.
• W169768324 hasConcept C54355233 @default.
• W169768324 hasConcept C553184892 @default.
• W169768324 hasConcept C55493867 @default.
• W169768324 hasConcept C62478195 @default.
• W169768324 hasConcept C7876069 @default.
• W169768324 hasConcept C81885089 @default.
• W169768324 hasConcept C86803240 @default.
• W169768324 hasConcept C95444343 @default.
• W169768324 hasConceptScore W169768324C101544691 @default.
• W169768324 hasConceptScore W169768324C109159458 @default.
• W169768324 hasConceptScore W169768324C128240485 @default.
• W169768324 hasConceptScore W169768324C153911025 @default.
• W169768324 hasConceptScore W169768324C170493617 @default.
• W169768324 hasConceptScore W169768324C2022786 @default.
• W169768324 hasConceptScore W169768324C28328180 @default.
• W169768324 hasConceptScore W169768324C502942594 @default.
• W169768324 hasConceptScore W169768324C54355233 @default.
• W169768324 hasConceptScore W169768324C553184892 @default.
• W169768324 hasConceptScore W169768324C55493867 @default.
• W169768324 hasConceptScore W169768324C62478195 @default.
• W169768324 hasConceptScore W169768324C7876069 @default.
• W169768324 hasConceptScore W169768324C81885089 @default.
• W169768324 hasConceptScore W169768324C86803240 @default.
• W169768324 hasConceptScore W169768324C95444343 @default.
• W169768324 hasIssue "7" @default.
• W169768324 hasLocation W1697683241 @default.
• W169768324 hasLocation W1697683242 @default.
• W169768324 hasOpenAccess W169768324 @default.
• W169768324 hasPrimaryLocation W1697683241 @default.
• W169768324 hasRelatedWork W1963652002 @default.
• W169768324 hasRelatedWork W1969354036 @default.

• next